Novartis and Microsoft join forces to develop drugs using AI

Five-year agreement is one of the most expansive tie-ups between big pharma and big tech - Financial Times

Oct 1, 2019 1 min read

I led a team to create a Microsoft Research partnership with Novartis Cell & Gene therapy, which was a key component of a broader Microsoft-Novartis partnership.

Innovator and leader in molecular and genetic programming